The application discloses a
lactobacillus delbrueckii subsp. lactis OG55 and application and products, and belongs to the technical field of microorganisms. A technical problem to be solved is that existing oral
probiotic research is mostly focused on the
inhibitory effect of a
single strain on a single target bacterium, and the
colonization ability and stability of the strain in an oral environment are insufficient. The application provides a
lactobacillus delbrueckii subsp. lactis OG55. The strain can inhibit three key oral
pathogenic bacteria, namely
porphyromonas gingivalis,
fusobacterium nucleatum and
streptococcus mutans, the inhibition rate of the strain on the formation of a
streptococcus mutans
biofilm reaches 72%, the strain has low self
biofilm formation ability, strong adhesion ability to hydroxyapatite and oral epithelial cells, and excellent
colonization stability; the strain can reduce the gingival index, periodontal pocket depth and inflammatory
factor level of
periodontitis symptoms, improve the enamel volume and
mineral density of dental caries, reduce
smooth surface caries and pit and
fissure caries damage, prevent and treat
digestive tract tumors, and has high safety and no
drug resistance.